| Id |
Subject |
Object |
Predicate |
Lexical cue |
| tok1 |
0-1 |
DT |
denotes |
A |
| tok2 |
2-6 |
NN |
denotes |
Call |
| tok3 |
7-10 |
IN |
denotes |
for |
| tok4 |
11-21 |
NNP |
denotes |
Randomized |
| tok5 |
22-32 |
NNP |
denotes |
Controlled |
| tok6 |
33-39 |
NNP |
denotes |
Trials |
| tok7 |
40-42 |
TO |
denotes |
to |
| lookup1 |
40-42 |
country_code |
denotes |
to |
| tok8 |
43-47 |
NNP |
denotes |
Test |
| tok9 |
48-51 |
DT |
denotes |
the |
| tok10 |
52-60 |
NNP |
denotes |
Efficacy |
| tok11 |
61-63 |
IN |
denotes |
of |
| tok12 |
64-75 |
NNP |
denotes |
Chloroquine |
| tok13 |
76-79 |
CC |
denotes |
and |
| tok14 |
80-98 |
NNP |
denotes |
Hydroxychloroquine |
| tok15 |
99-101 |
IN |
denotes |
as |
| lookup2 |
99-101 |
country_code |
denotes |
as |
| tok16 |
102-114 |
NNP |
denotes |
Therapeutics |
| tok17 |
115-122 |
IN |
denotes |
against |
| tok18 |
123-128 |
NNP |
denotes |
Novel |
| tok19 |
129-140 |
NNP |
denotes |
Coronavirus |
| tok20 |
141-148 |
NNP |
denotes |
Disease |
| tok21 |
149-150 |
( |
denotes |
( |
| tok22 |
150-156 |
NNP |
denotes |
COVID- |
| tok23 |
156-158 |
CD |
denotes |
19 |
| tok24 |
158-159 |
) |
denotes |
) |
| tok25 |
159-160 |
. |
denotes |
. |
| tok26 |
161-164 |
DT |
denotes |
The |
| tok27 |
165-173 |
NNP |
denotes |
American |
| lookup3 |
165-173 |
country_adj |
denotes |
American |
| tok28 |
174-181 |
NNP |
denotes |
Society |
| lookup4 |
174-181 |
org_base |
denotes |
Society |
| tok29 |
182-184 |
IN |
denotes |
of |
| tok30 |
185-193 |
NNP |
denotes |
Tropical |
| tok31 |
194-202 |
NNP |
denotes |
Medicine |
| tok32 |
203-206 |
CC |
denotes |
and |
| tok33 |
207-214 |
NNP |
denotes |
Hygiene |
| tok34 |
214-215 |
. |
denotes |
. |
